These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 36625486)

  • 1. A novel prognostic system combining carbonic anhydrase II and preoperative CA19-9 for intrahepatic cholangiocarcinoma after curative resection.
    Zhang J; Huang Q; Yang Y; Zhang J; Fang X; Yang Y; Liang H; Wang W; Wang Y
    Cancer; 2023 Apr; 129(7):1030-1040. PubMed ID: 36625486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
    Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictive value of HTS grade in patients with intrahepatic cholangiocarcinoma undergoing radical resection: a multicenter study from China.
    Huang G; Zhang H; Yang Z; Li Q; Yuan H; Chen P; Xie C; Meng B; Zhang X; Chen K; Yu H
    World J Surg Oncol; 2024 Jan; 22(1):17. PubMed ID: 38200585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A novel nomogram for individualized preoperative prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma].
    Ma WH; Lei ZQ; Yu QS; Xiao QR; Tang HL; Si AF; Yang PH; Cheng ZJ
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):363-371. PubMed ID: 35272428
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
    Zhu J; Wang D; Liu C; Huang R; Gao F; Feng X; Lan T; Li H; Wu H
    Front Immunol; 2023; 14():1165510. PubMed ID: 37063918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preoperative scoring system combining neutrophil/lymphocyte ratio and CA19-9 predicts the long-term prognosis of intrahepatic cholangiocarcinoma patients undergoing curative liver resection.
    Bai S; Shi X; Dai Y; Wang H; Xia Y; Liu J; Wang K
    BMC Cancer; 2024 Sep; 24(1):1106. PubMed ID: 39237882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic Cholangiocarcinoma.
    Alaimo L; Moazzam Z; Endo Y; Lima HA; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
    Ann Surg Oncol; 2023 Mar; 30(3):1392-1403. PubMed ID: 36383331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study.
    Yu H; Wang M; Wang Y; Yang J; Deng L; Bao W; He B; Lin Z; Chen Z; Chen K; Zhang B; Liu F; Yu Z; Ye L; Jin B; Chen G
    Cancer Med; 2021 Jul; 10(14):4768-4780. PubMed ID: 34105304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival analysis of intrahepatic cholangiocarcinoma after resection.
    Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
    Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of Normalization of Carbohydrate Antigen 19-9 in Patients With Intrahepatic Cholangiocarcinoma.
    Li H; Feng Y; Liu C; Li J; Li J; Wu H; Wang G; Li D
    Front Oncol; 2021; 11():780455. PubMed ID: 35004301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Tumor Burden Score and Carbohydrate Antigen 19-9 Grading System to Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma.
    Moazzam Z; Alaimo L; Endo Y; Lima HA; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Cloyd J; Ejaz A; Pawlik TM
    J Am Coll Surg; 2023 Apr; 236(4):804-813. PubMed ID: 36728327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of preoperative CA19-9 and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Asaoka T; Kobayashi S; Hanaki T; Iwagami Y; Tomimaru Y; Akita H; Noda T; Gotoh K; Takeda Y; Tanemura M; Doki Y; Eguchi H
    Surg Today; 2020 Oct; 50(10):1176-1186. PubMed ID: 32221659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical Indication for Advanced Intrahepatic Cholangiocarcinoma According to the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value.
    Yamamoto Y; Sugiura T; Todaka A; Okamura Y; Ito T; Ashida R; Kakuda Y; Nakanuma Y; Uesaka K
    World J Surg; 2018 Oct; 42(10):3331-3340. PubMed ID: 29619514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of interleukin-35 in intrahepatic cholangiocarcinoma is a prognostic indicator after curative resection.
    Zhang MX; Gan W; Jing CY; Zheng SS; Zhang J; Shen HJ; Xu X; Lin JJ; Zhang BH; Qiu SJ
    Cancer Sci; 2018 Apr; 109(4):1195-1206. PubMed ID: 29446854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection.
    Li XH; Zhao CY; Zhou EL; Lin XJ
    BMC Cancer; 2022 Nov; 22(1):1159. PubMed ID: 36357848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma.
    Cai WK; Lin JJ; He GH; Wang H; Lu JH; Yang GS
    Int J Clin Exp Pathol; 2014; 7(11):7890-8. PubMed ID: 25550829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The analysis of long-term prognostic factors after laparoscopic liver resection for intrahepatic cholangiocarcinoma and establishment of survival Nomogram model].
    Shen ZF; Chen C; Geng ZM; Mao XH; Li JD; Song TQ; Sun CD; Wu H; Cheng ZJ; Lin RX; He Y; Zhai WL; Tang D; Tang ZH; Liang X
    Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):939-947. PubMed ID: 36207983
    [No Abstract]   [Full Text] [Related]  

  • 18. The combination of preoperative D-dimer and CA19-9 predicts lymph node metastasis and survival in intrahepatic cholangiocarcinoma patients after curative resection.
    Chen Q; Zheng Y; Zhao H; Cai J; Wang L; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Wu J
    Ann Transl Med; 2020 Mar; 8(5):192. PubMed ID: 32309339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study.
    Zhang G; Chen BW; Yang XB; Wang HY; Yang X; Xie FC; Chen XQ; Yu LX; Shi J; Lu YY; Zhao HT
    World J Gastroenterol; 2022 Nov; 28(41):5968-5981. PubMed ID: 36405111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of serum carbohydrate antigen 19-9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
    Yamada T; Nakanishi Y; Okamura K; Tsuchikawa T; Nakamura T; Noji T; Asano T; Tanaka K; Kurashima Y; Ebihara Y; Murakami S; Shichinohe T; Mitsuhashi T; Hirano S
    J Gastroenterol Hepatol; 2018 Feb; ():. PubMed ID: 29427472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.